Call Us: +91-779-979-0002/+91-779-979-0003

Plenary Talks

Abstract

Symposium and/or Oral Presentation Title: A novel tracheotomy speaking valve and Heat Moisture Exchanger Encyclopedia of Bioanalytical Methods for Bioavailability and Bioequivalence Studies of Pharmaceuticals Name: Alan H. Shikani MD, FACS The Maryland Nose & Sinus Center MedStar Union Memorial Hospital, Baltimore, Maryland 21218 USA Tracheotomy affectsthe patient, at a very basic level: the ability to communicate. With the presence of a tracheotomy tube, airflow is diverted away from the vocal folds, often deeming the patient aphonic. One-way speaking valves are designed to redirect exhaled air to the vocal folds and restore speech; most of the valves that have been described in the literature and that are on the market operate via flapper membrane that opens upon inhalation and closes upon exhalation. A newer type of unidirectional speaking valve, the ball speaking valve, is based on a moving ball inside a chamber which rolls back toward the trachea upon inhalation, allowing air enters through the cannula and then forward upon exhalation, forcing the air to flow through the larynx and allowing speech. The ball valve offers several advantages over the flapper membrane valves, including substantially lower airflow resistance which translates into enhanced patient toleranceand ease of breathing, along with significantly superior voice naturalness and voice quality and superior restoration of the loss of smell that is typically lost after a tracheotomy. Another major advantage of the ball valve is its unique ability to be used in combination with anovel type of Heat Moisture Exchanger (HME), allowing the patient to speak and humidify at the same time, a paradigm shift in the care of tracheotomy patients. The HME helps restore the normal functions of the nose, which is the natural organ of the body that is responsible for air humidifying, warming and filtering of the body. Biography Alan Shikani MD, FACS did his residency and fellowship training in Otolaryngology-Head & Neck surgery at the Johns Hopkins Hospital and is currently the Chief of Otolaryngology-Head & Neck Surgery at the LifeBridge Sinai Hospital, MedStar Union Memorial Hospital, and MedStar Good Samaritan Hospital in Baltimore. He is also the founder of the Maryland ENT Center Group and Director of the Maryland Nose & Sinus Rhinology Fellowship program. Dr Shikani is an active member of many distinguished societies including the Alpha Omega Honor Medical Society, the Triologic society, the American College of Surgeons, the American Academy of Otolaryngology and the American Rhinological Society. He has published numerous articles and book chapters in the field of Otolaryngology-Head & Neck surgery. He is the winner of the prestigious Maurice H. Cottle Award presented by the American Rhinological Society for his work on cartilage tissue engineering using nasal septal chondrocytes. He is the winner of the Basic Science Research award of the American Society of Head & Neck Surgery for his work on targeted immunotherapy for head and neck cancer. His Triological Society thesis pioneered the field of polymer chemotherapy for head and neck cancer.

Biography

Alan Shikani MD, FACS did his residency and fellowship training in Otolaryngology-Head & Neck surgery at the Johns Hopkins Hospital and is currently the Chief of Otolaryngology-Head & Neck Surgery at the LifeBridge Sinai Hospital, MedStar Union Memorial Hospital, and MedStar Good Samaritan Hospital in Baltimore. He is also the founder of the Maryland ENT Center Group and Director of the Maryland Nose & Sinus Rhinology Fellowship program. Dr Shikani is an active member of many distinguished societies including the Alpha Omega Honor Medical Society, the Triologic society, the American College of Surgeons, the American Academy of Otolaryngology and the American Rhinological Society. He has published numerous articles and book chapters in the field of Otolaryngology-Head & Neck surgery. He is the winner of the prestigious Maurice H. Cottle Award presented by the American Rhinological Society for his work on cartilage tissue engineering using nasal septal chondrocytes. He is the winner of the Basic Science Research award of the American Society of Head & Neck Surgery for his work on targeted immunotherapy for head and neck cancer. His Triological Society thesis pioneered the field of polymer chemotherapy for head and neck cancer.

Speaker
Alan H. Shikani / MedStar Union Memorial Hospital, USA

Abstract

A New Technique for Sphenopalatine Ganglion Block (SPGB) for the Treatment of Face Pain Adam Frosh FRCS Consultant otolaryngologist, Lister Hospital, Stevenage, SG1 4AB, UK Neuropathic face pain including atypical face pain and trigeminal nerve neuralgia are often associated with significant loss of quality of life for the sufferer. They are often unresponsive to conventional treatments such as anticonvulsants and tricyclic antidepressants, which are often poorly tolerated and can cause significant side-effects. Although SPGB has been shown to be a safe and effective treatment, it has been unpopular largely because access to the ganglion is anatomically difficult. Our novel technique delivers 1 ml of 1% lidocaine and depomedrone 40 mg submucosally over the vertical plate of palatine bone via a trans-nasal approach, under direct vision using a nasal endoscope. We present 26 patients (13m, 13f) with forms of face pain resistant to conventional treatment. Seven reported complete resolution of their pain, six reported their pain had improved and thirteen were unchanged. Given the patient selection included recalcitrant, long-standing symptoms of face pain, a significant improvement in 50% of the subjects would indicate this technique to be a serious consideration for the treatment for future patients. The technique is straightforward and can easily be delivered by otolaryngologists familiar with the basic techniques of endoscopic sinus surgery. Biography Adam Frosh is a consultant Otolaryngologist who's worked at the Lister Hospital, UK for 18 years. He has been heavily involved in research into prion diseases at the MRC and how they affect the practice of Otolaryngology. He is also an Honorary Senior Lecturer at the University of Hertfordshire, UK and an Honorary Research Fellow at the MRC Institute of Prion Diseases. He has published over 50 scientific works in the literature and has published a book on hosting fine dining dinner parties at home.

Biography

Adam Frosh is a consultant Otolaryngologist who's worked at the Lister Hospital, UK for 18 years. He has been heavily involved in research into prion diseases at the MRC and how they affect the practice of Otolaryngology. He is also an Honorary Senior Lecturer at the University of Hertfordshire, UK and an Honorary Research Fellow at the MRC Institute of Prion Diseases. He has published over 50 scientific works in the literature and has published a book on hosting fine dining dinner parties at home.

Speaker
Adam Frosh / Lister Hospital, UK

Abstract

The association between neck properties, voice and the perception of gender is crucial, both theoretically and clinically, especially when the perception of speakers' gender is of interest, such as in transgender patients. Therefore, this study was a preliminary attempt to examine this association. One hundred and twenty-four adults subjectively evaluated and rated audio recordings and high-resolution photographs of necks, obtained from 30 women and men.Basic acoustic measures were extractedfrom the recordings of each speaker.In additoin, physical properties of the neck were measured for each speaker. First, results confirmed that, as expected, all acoustic measures revealed a significant difference between men and women's voices. Yet, in a stepwise multiple regression model, only mean-f0 and F2 predicted perceptual gender assessment (corrected p< 0.05). While most physical measures of the neck were larger for men, neck length did not significantly differ between genders. A stepwise multiple regression model revealed that the single physical measure that consistently differed between genders was neck-girth (p< 0.0001). The single visual-appearance measure that consistently differed between genders was thyroid-protrusion (p= 0.0003). Finally, neck-girth significantly predicted gender differences in the acoustic measures. In conclusion, neck characteristics are significantly associated with voice and with the perception of gender. Nonethelss, while larger necks are, indeed, perceived as masculine, neck length is not associated with gender, nor with the speaker's voice characteristics. Beyond the theoretical merit of these findings, they may improve personalizing treatment and clinical decision-making, in cases where gender perception is of interest.

Biography

Prof. Ofer Amir has completed his PhD from the University of Illinois, USAand postdoctoral studies from Tel Aviv University, Israel. He is the former head of the Department of Communication Disorders at Tel Aviv University, and currently an Associated Professor. He has authored more than 65 peer-reviewed articles and book chapters in the fields of voice, speech and fluency disorders.In addition to his academic and research activities, he is also a practicing Speech Pathologist

Speaker
Ofer Amir / Tel Aviv University, Israel

Abstract

Transoral CO2 Laser Microsurgery (TLM) is an alternative treatment to (chemo)radiotherapy for early glottic and hypopharyngeal cancer. Seventy-seven early glottic cancer patients were treated by TLM alone during from 1986 to 2011 in Kurume University Hospital. The 5-year local control rate of TLM was 93.0%. The patients' phonatory functions were significantly poor after type III cordectomy that included the anterior macula flava. TLM for early glottic cancer can be satisfied with laryngeal preservation and postoperative vocal function. TLM for early hypopharyngeal cancer also enables to avoid (chemo)radiotherapy. Sixty hypopharyngeal cancer patients were treated by TLM during from 1995 to 2014 in our hospital. The 5-year local control rate of PS, PW, PC were 92%, 86%, 50% respectively. Postoperative dysphasia appeared after TLM as follows, mild: 8(13%), moderately; 4(7%), severe; 0 respectively. A precise understanding of the histoanatomical characteristics of the hypopharynx increase the success of TLM, decrease complication rates and improves laryngeal preservation. Super-selective intra-arterial infusion with cisplatin and concurrent radiotherapy (RADPLAT) is also a good alternative treatment modality to chemoradiotherapy especially for T3 laryngeal cancer. Seventy T3 laryngeal cancer patients were treated by operation; 31, CRT; 10, RADPLAT; 29 respectively during from 2004 to 2013 in our hospital. The 5-year local control rate of operation, CRT, RADPLAT were as follows, 96%, 78%, 78%. However, the 5-year Laryngo-esophageal dysfunction free survival rates of operation, CRT, RADPLAT were as follows, 0%, 45%, 65%. RADPLAT will enable true laryngeal preservation in patients with T3 laryngeal cancer in comparison to CRT.

Biography

Prof. Umeno has completed his Ph.D from Kurume University and postdoctoral studies from Kurume University School of Medicine. He is the director of the Japan laryngological Association. Board member of Japan Society of Broncho-Esophagology, Japan Association of Logopedics and Phoniatrics, The Society of Swallowing and Dysphagia of Japan, and member of American Broncho-Esophagological Association (ABEA) . He is also the councilor of Japan Society of Head and Neck Cancer, The Japan Society for Head and Neck Surgery, and member of Asian Society of Head and Neck Oncology (ASHNO). He has published more than 65 papers in reputed journals.

Speaker
Hirohito Umeno / Kurume University School of Medicine, Japan

Sessions:

Abstract

This study assessed a two-stage model for universal neonatal hearing screening by Automated ABR. The first hearing screening completed for each newborn after 24 hours of birth and repeated the test after two weeks for those who failed. The model evaluated during Calendar year 2018 in a maternity ward with 300 newborns. The newborn hearing screening program admitted 300 newborns who delivered in a period between January 2018 and December 2018 and among them, 10 failed unilaterally in the initial screening and advised to follow up with an audiologist to repeat the test after two weeks. The second stage hearing screening completed for six infants, those who failed in the initial screening. In the second stage of hearing screening, five among the six passed both ears and one case with congenital unilateral atresia failed in one ear. The primary outcome of this model was coverage of 99.5 percentage of infants delivered in the hospital. The newborns were screened at the maternity ward with a total time of fewer than 15 minutes per child. The sensitivity and specificity were the secondary outcomes of this evaluation and they were similar to those of previous studies,which evaluating the screen procedure on a larger scale, giving a sensitivity of approximately 100%. The clinical implications of this model were early identification of severe congenital hearing impairment before the age of one month and intervention before the age of six months. The data demonstrates that universal hearing screening is feasible within the existing healthcare culture of United Arab Emirates with remarkable coverage,sensitivity and specificity.

Biography

Ms.Ranjini Sanoop has completed her graduation from Calicut University and Post graduation from Kerala University of Health sciences, India. She is the Head of the department of Audiology, Emirates Specialty Hospital And Dr Rami Hamed Center in Dubai healthcare city. She has been serving as a registered member of Rehabilitation Council of India and a licensed Audiologist in Dubai Healthcare city. She has completed her dissertation entitled, ‘Writing test for Malayalam-English Bilingual aphasics (2012)’Guided by Dr Swapna Sebastian, Associate Professor, Vellore Medical College and presented a research paper entitled “A Comparative Study on Method of Non-Verbal Communication Skills of Children with Mild to Moderate and Severe Autism (2011)” on National Conference on Autism, ICCONS, Shoranur, Kerala, India.

Speaker
Ranjini Sanoop / Kerala University of Health sciences, India

Abstract

Hearing impairment is considered the most prevalent impairment worldwide. Congenital hearing loss due to hereditary factors accounts to 50% of cases in which consanguinity play an important etiological role. In Saudi Arabia, the prevalence is higher than western nations. While consanguineous marriages are encouraged as part of the social customs and traditions (Zakzouk, 2002). The purpose of this survey is to identify the incidence of consanguinity among the parents of sensory - neural hearing impaired children in the last 5 years and compares the result with precedent study. A retrospective study was carried out in 142 patients with mean age of 5.61 years who attended king Fahad hospital in Jeddah. The results showed that 37.32 %( 53) of the cases were products of consanguineous matting and 62.68% (89) were born to non-consanguineous parents.

Biography

Speaker
Yassmin Aljedaani / ENT consultant and Cochlear implant surgeon,Saudi Arabia.

Abstract

Benign nasal cavity tumors are not common entity with anatomopathological diversity, poor clinical symptomatology and an uncontrolled therapeutic protocol dominated by surgery.It is necessary to distinguish the relatively frequent histological varieties: inverted papillomas, hemangiomas and others rarer or even exceptional, pleiomorphic adenoma, osteomas, chondromas and schwannomas. The diagnostic approach is based on a three ways: nasal endoscopy, imaging (CT-MRI) and biopsy. The evolutionary profile remains marked by the risk of recurrence (incomplete excision) and malignant transformation. This study reports the results of a series of 70 cases of exclusively endonasal benign tumors collected between January 1998 and December 2017. The age of the patients varies between 10 and 80 years with an average of 46 years. The distribution by sex shows 38 women for 32 men. Topographically tumors of the nasal septum are the most frequent followed by the the lateral wall of the nasal cavity. we report a predominance of vascular histologic variety (hemangiomas) followed by epithelial variety (inverted papillomas).Other uncommun varieties (leiomyoma, pleomorphic adenoma) have been noted. The treatment was surgical (external or endoscopic) with, in one case, complementary radiotherapy (inverted papilloma associated with squamous cell carcinoma). A discussion with review of the literature is made at the end of these results.

Biography

KHAROUBI SMAIL, professor - ENT head and neck surgery en ORL . Departement of ENT head and neck surgery. DR DORBAN- HOSPITAL. CHU ANNABA -FACULTY OF MEDICINE - UNIVERSITY BADJI MOKHTAR ANNABA 23000 ALGERIA. FIELDS OF INTEREST: rhinology, olfactology, reconstructive surgery, pediatric ENT, rare tumors in ENT, genetics and ENT, robotics and ENT. LAST PUBLICATION: 1-Benign tumors of the nasal cavity, new classification and review of the literature. Report of 54 cases .Kharoubi S.Rev Laryngol Otol Rhinol (Bord). 2015;136(4):131-42.2- Kikuchi Fujimoto, one case report and review of the literature.Kharoubi S.Rev Laryngol Otol Rhinol (Bord). 2015;136(3):125-8 3- Lipoma of the floor of the mouth: Case report and literature review.Kharoubi S.Rev Laryngol Otol Rhinol (Bord). 2014;135(3):157-60 4- Cutaneous horn of the pinna.Kharoubi S.Rev Laryngol Otol Rhinol (Bord). 2011;132(4-5):231-2.5- Pneumatization (concha bullosa) of the inferior turbinate: cas report and literature review.Kharoubi S.Rev Laryngol Otol Rhinol (Bord). 2010;131(4-5):321-4.

Speaker
KHAROUBI SMAIL / UNIVERSITY BADJI MOKHTAR ANNABA 23000 ALGERIA.

Abstract

For over 3 decades, Electrocochleography (ECochG) has been used as a clinical tool, primarily in the diagnosis, assessment and management of Meniere‘s disease (MD)/endolymphatic hydrops (ELH). While this application continues to be a primary one for ECochG, several others have emerged over the years. This presentation will focus on new/emerging uses for ECochG including: • diagnosis of superior semicircular canal dehiscence and monitoring the status of the inner during the surgical repair of this condition • assessment of hidden hearing loss; • diagnosis of auditory neuropathy in children • intraoperative monitoring during cochlear implant surgery. More recently, research in our laboratory has shown that ECochG may possibly be useful in the prediction of MD/ELH in the offspring/siblings of individuals with a confirmed diagnosis. The continued importance of ECochG as a clinical tool in hearing health care also will be discussed along with the need to develop more standardized guidelines for recording, measuring and interpreting the electrocochleogram.

Biography

Speaker
John A. Ferraro / University of Kansas Medical Center.Usa

Abstract

Endoscopic Ear surgery (EES) has been in practice for nearly two decades. The advantages of EES include its minimal invasiveness and unparalleled visualisation of the middle ear along with its recesses. However despite these advantages, isEES more effective than canal wall down (CWD) or canal wall up (CWU) techniques in the management of cholesteatoma? Aims and objectives Our study aims were to systematically review the literature to establish the effectiveness of EES in cholesteatoma. Materials and Methods A search was performed using Cochrane, Embase and Pubmed. Inclusion criteria were 1) Studies reporting Endoscopic Ear Surgery alone (EES3) or as an adjunct to microscopic ear surgery (EES 2) for treatment of middle ear/mastoid cholesteatoma 2) Primary cases 3) English articles. The exclusion criteria for this study were 1) Articles reporting revision cases only2) Reports discussing management of non-cholesteatoma disease 3) Non-English articles. Results A total of 963 patients from 15 studies were included. Mean follow up was 25.84 months. There were 380 and 583 patients in the EES2 and EE3 categories respectively. 343 patients were followed between 0 and 2 years, 376 patients between 2 and 4 years and 244 patients over 4 years. Overall residual/recurrence rate was 18.69%. Conclusions All published literature is of level 4 Evidence. EES is safe and has a key role in the management of cholesteatoma. The recurrence/residual rates of EES are comparable with CWU mastoidectomy at 2 years post surgery. High quality controlled trials are required to demonstrate its long-term effectiveness.

Biography

Speaker
Vikranth Viswanath / UK

Abstract

Importance: The current objective for treating low stage +p16 associated oropharyngeal cancer should be maximal efficacy with minimal toxicity. Toward that end, we have de-escalated therapy by selectively eliminating intentional irradiation of the primary site in selected patients undergoing intensity modulated radiation therapy (IMRT) after definitive trans-oral robotic surgery (TORS) surgery. Objective: To determine if sparing radiation to the oropharynx following TORS for oropharyngeal squamous cell carcinoma OPSCC impacts local control. Methods: We established an institutional policy of selective non-irradiation of the primary site of disease after TORS surgery for low stage HPV-associated oropharyngeal cancer. From October 2016 to October 2018, 85 patients with p16+ level 2a nodal disease underwent TORS + ipsilateral neck dissection level Ib-IV for T0-T1 OPSCC at a tertiary care academic comprehensive cancer center. No patient had a history of squamous cell carcinoma skin cancer. After personal discussion between the surgeon and the radiation oncologist before postop radiation was designed, adjuvant radiation to the primary was omitted if margins were >/= 3 mm and a deep margin > 1 mm and both physicians were comfortable. Adjuvant chemotherapy was incorporated for extranodal extension (ENE). Results: Twenty-nine consecutive patients with pathologic stage T0-T1, N1-2 (8th Ed. AJCC) OPSCC, with an average age of 62.3 years were treated. 25 of 29 (86%) presented as carcinoma of unknown primary (CUP). Tumor location was identified in 20 of 25 (80%), 12 (60%) located in the tongue base, 8 (40%) in the tonsil. 16 of 20 (80%) of CUP were entirely excised during TORS excisional biopsy of ipsilateral palatine/ bilateral lingual tonsillectomy. Mean tumor size was 1.2cm (0.2 - 2.2 cm). ENE rate was 31% (n = 9), of which was 21% (n = 6) macroscopic. Perineural invasion and Lymphovascular invasion were identified in 8.3% and 41.7%, respectively. In 15 of 29 (52%) cases, radiation therapy (RT) to the oropharyngeal site was spared. Mean follow-up time ongoing and is currently 8 months (1-21.7). No patient has experienced local, regional, or distant recurrence. Former smokers accounted for 72% of patients, 48% noting > 10 pack years. Conclusions: Sparing adjuvant RT to the primary site for HPV-associated CUP and T1 OPSCC may not compromise local control. Results continue to mature and long-term follow-up is needed. The most significant benefit may be in establishing a clinical protocol sparing RT to the primary for CUP.

Biography

Mihir R. Patel, MD, is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine. Dr. Patel focuses on minimally invasive surgical techniques to treat head and neck cancers. His interest in preserving functional outcomes for patients led to fellowship training in transoral robotic surgery (TORS) at the University of Pennsylvania. Prior to receiving TORS training, Dr. Patel completed a fellowship in minimally invasive, endoscopic skull base surgery at The Ohio State University Skull Base Center. Prior to his journey into the medical field, he was a chemistry teacher in Brooklyn, NY where he dedicated his time to a population with scarce resources and tried to support the community efforts towards education with after-school tutoring lessons. Dr. Patel's shift to medicine was triggered by a long standing memory of a student he tutored who died from cancer. He is dedicated to research efforts in head and neck cancer genomics. He was a member of the Winship team that participated in the ECOG 3311 human papilloma virus (HPV) oropharyngeal de-escalation trial.

Speaker
Mihir R. Patel / Emory University School of Medicine, United States

Abstract

Objectives The aim of this study was to compare the efficiency of cinnarizine and topiramate as prophylactic therapy for vestibular migraine. Methods In this randomized, double-blind,single-center clinical trial 72 migrainous (from 18–60 years of age) attending at outpatient clinic ofMenoufia university hospitals for treatment of vestibular migraine were equally allocated to receive cinnarizine or topiramate. The primary outcome was monthly migraine frequency. Secondary outcome was monthly migraine intensity. Efficiency measures were recorded at the baseline and at 2, 4, and 12 weeks of treatment. Results During the double-blind phase of the study, monthly migraine frequency and intensity were significantly decreased in both the cinnarizine and topiramate groups when compared to the baseline. No significant difference between cinnarizine and topiramate was found for prevention of vestibular migraine. Conclusion No significant difference between cinnarizine and topiramate was found for prevention of vestibular migraine. Cinnarizinewasbetter tolerated.

Biography

Audiology Unit,Faculty of Medicine,Menoufia University,Egypt.

Speaker
Nancy Fathy Omran / Menoufia University, Audiology Unit,Faculty of Medicine Egypt

Abstract

Objective: to assess and early discover subtle changes in hearing sensitivity caused by personal audio devices (PADs). Methods: Participants aged from 14 to 21 years were selected through simple random sampling and those willing were enrolled after written informed consent. The participants were divided into two groups: Group I (Study group) with history of regular use of PAD and Group II (control group) who never use PAD. All participants had undergone pure tone audiometry (PTA), extended high frequency (EHF) audiometry, immitencemetry and transient evoked optoacoustic emissions (TEAOE). Questionnaire was conducted only for the study group Results: The average duration of PADs use in the study group was 2 years with 68.29 % of them used it ≥ 4 days/ week, 63.41 % used it for ≥ one hour daily and 39.02 % prefer very loud volume. Tinnitus was the most important problem that occurred immediately after PADs use, followed by hearing loss. EHF audiometry showed highly statistically significant differences in the threshold between study and control groups. The more hearing threshold shift occurred with the PADs group who used it for ≥ 2 years. TEOAE amplitude was lower in PLD users than in the control group. Conclusion: The current study suggest that the long-term use of PLDs can impair hearing function, so a screening protocol should be considered for early identification of NIHL in PLDs users.

Biography

Salwa. Mourad has completed her MD from Sohag University, faculty of Medicine, Egypt. She is an asisstant professor of Audio-vestibular Medicine, Faculty of Medicine, Sohag University, Egypt, and a Consultant of Audiovestibular Medicine at East Jeddah Hospital KSA. She has published 9 papers in reputed journals and has been serving as a reviewer member of reputed journals.

Speaker
Salwa Mourad Abelmawgoud Elsayed / Sohag University Faculty of Medicine, Egypt

Abstract

The objectives of this study were to assess the oral malodor in patients and analyze its association with prosthetic status of them. The study comprised 94 patients [60 males and 34 females] between the ages of 34 and 68 years old. This cross-sectional survey was carried out at the ENT department of the Metaxas Cancer hospital. Oral malodor was assessed by two clinician judges using the organoleptic method. There was agreement between the two clinicians. The prevalence of malodor was high [43,33%] in the men who worn complete or partial dentures. Ten patients [16,66%] with faulty fixed partial dentures had bad breath. There was a high percent [47,05%] of the halitosis in females who worn unclean removable dentures.

Biography

Fotoula Nikolopoulou has been graduated from from the Dental School of the University of Athens in 1979. She has been graduated from the Medical School of the University of Athens. She got her PhD from the Dental School of the University of Athens in 1994. She has worked as a lecturer at the department of Prosthodontics of the Dental of Athens in 1995. She has done her Residency Program and Implantology, in the School of Dental Medicine, of the University of Pittsburgh during 2002-2003. She got her Master’s degree in Public Health from the Univesrity of Pittsburgh in 2004. She has been working as an Assistant Professor at the department of Prosthodontics of Dental School, of the University of Athens from 2008.

Speaker
Fotoula Nikolopoulou / National and Kapodistrian University of Athen, Greece

Abstract

Background: The aim of this study was to compare the long-term effect of columellar strut and septal extension graft on the stability of nasal tip projection and definition. Methods: A comparison was done on the difference between early and long term results of the nasal tip projection in 52 patients divided into two groups between 2015 and 2018. All cases were done by the same surgeon. Results: Both grafts have the effects of increasing tip projection and this effect was found to be stable over time. However, some increased values of nasal tip projection obtained in the early postoperative period, in columellar strut cases, were lost over time. Conclusions: The tip projection and definition were more stable in cases with septal extension graft than in those with columellar strut.

Biography

Dr. Yasser Elbadawy was graduated from Cairo university on 1990. After his graduation he had his initial training at Ahmed Maher teaching hospital (one of the biggest teaching hospitals in Egypt with more than 1000 bed). During this time he obtained his master degree in surgery after his research in cleft palate repair. Later on, he earned the degree of Fellowship of the royal college of surgeon of Ireland and European Board of plastic, Aesthetic, and reconstructive surgery. In addition, Dr. Yasser earned his medical doctorate degree in surgery after his thesis in self-inflating tissue expanders in the field of reconstructive surgery. Along with obtaining most of the valuable degrees in plastic and reconstructive surgery, he is also a member of several organizations of plastic surgery like, ASAPS, ISAPS, European society of rhinoplasty surgery, Mediterranean burn club and many more. After close contact with the pioneers of plastic surgery and attending several excessive courses in the field of rhinoplasty, he gained the advanced fellowship in secondary rhinoplasty from Bergamo state hospital, Italy. Dr. Yasser Elbadawy, is an expert in primary, secondary, and tertiary rhinoplasty, and has contributed in different types of teaching and research done in all the hospitals he has worked in.

Speaker
Yasser ElBadawy / Cairo University Egypt

Abstract

Timely and accurate diagnosis of premalignant and malignant laryngeal lesions is the most important in selecting a therapeutic strategy and treatment outcome. Microlaryngoscopy is today a standard diagnostic, often therapeutic procedure, for various cases of laryngeal pathology. The purpose of this procedure is to detect the pathological change, describe its size and extent, appearance, and if possible, to remove it. Even for experienced laryngologists, microlaryngoscopy can be a difficult task due to various reasons. Autofluorescent laryngeal endoscopy is based on the biophysical and biochemical characteristics of different tissue types. Healthy and pathologically altered tissues, primarily malignant tumors, have different metabolic characteristics. System of Autofluorescent Endoscopy (SAFE 1000) developed by Pentax was used to investigate diagnostic values in the diagnosis of premalignant and malignant laryngeal lesions. The results of the study showed that autofluorescence endoscopy has significantly higher sensitivity, but also significantly less specificity in the diagnosis of precancerous and malignant laryngeal tumors. Based on this research, it could be concluded that autofluorescence endoscopy can have great importance as an aditonal diagnostic procedure, especially for precancerous and malignant laryngeal lesions, but cannot replace microlaryngoscopy at this time. Key words: larynx, cancer, diagnostics, autofluorescent endoscopy

Biography

Dr. Nenad Baletic completed his doctoral studies at the Faculty of Medicine, University of Belgrade in 2005. He is the Head of the Department of Rhinolaryngology at the Military Medical Academy in Belgrade, Serbia. He has published 19 papers in different journals.

Speaker
Nenad Baletić / Military Medical Academy, Belgrade, Serbia

Plenary Talks

Abstract

Transoral CO2 Laser Microsurgery (TLM) is an alternative treatment to (chemo)radiotherapy for early glottic and hypopharyngeal cancer. Seventy-seven early glottic cancer patients were treated by TLM alone during from 1986 to 2011 in Kurume University Hospital. The 5-year local control rate of TLM was 93.0%. The patients' phonatory functions were significantly poor after type III cordectomy that included the anterior macula flava. TLM for early glottic cancer can be satisfied with laryngeal preservation and postoperative vocal function. TLM for early hypopharyngeal cancer also enables to avoid (chemo)radiotherapy. Sixty hypopharyngeal cancer patients were treated by TLM during from 1995 to 2014 in our hospital. The 5-year local control rate of PS, PW, PC were 92%, 86%, 50% respectively. Postoperative dysphasia appeared after TLM as follows, mild: 8(13%), moderately; 4(7%), severe; 0 respectively. A precise understanding of the histoanatomical characteristics of the hypopharynx increase the success of TLM, decrease complication rates and improves laryngeal preservation. Super-selective intra-arterial infusion with cisplatin and concurrent radiotherapy (RADPLAT) is also a good alternative treatment modality to chemoradiotherapy especially for T3 laryngeal cancer. Seventy T3 laryngeal cancer patients were treated by operation; 31, CRT; 10, RADPLAT; 29 respectively during from 2004 to 2013 in our hospital. The 5-year local control rate of operation, CRT, RADPLAT were as follows, 96%, 78%, 78%. However, the 5-year Laryngo-esophageal dysfunction free survival rates of operation, CRT, RADPLAT were as follows, 0%, 45%, 65%. RADPLAT will enable true laryngeal preservation in patients with T3 laryngeal cancer in comparison to CRT.

Biography

Prof. Umeno has completed his Ph.D from Kurume University and postdoctoral studies from Kurume University School of Medicine. He is the director of the Japan laryngological Association. Board member of Japan Society of Broncho-Esophagology, Japan Association of Logopedics and Phoniatrics, The Society of Swallowing and Dysphagia of Japan, and member of American Broncho-Esophagological Association (ABEA) . He is also the councilor of Japan Society of Head and Neck Cancer, The Japan Society for Head and Neck Surgery, and member of Asian Society of Head and Neck Oncology (ASHNO). He has published more than 65 papers in reputed journals.

Speaker
Hirohito Umeno / Kurume University School of Medicine, Japan

Sessions Will be updated soon...

Will be updated soon...